Position in ABBV
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$10,134,549
+$418,401 QoQ
Shares Held
40,274
-9.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
#911
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INDEPENDENT INVESTORS INC holds $43,440,882 across 7 Drug Manufacturers - General names. ABBV ranks #3 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
70,356 | $17,868,313 | |
| 2 | AMGN |
Amgen Inc
|
29,176 | $10,565,213 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
40,274 | $10,134,549 | |
| 4 | NVS |
Novartis AG
|
17,900 | $2,805,288 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
25,438 | $1,465,737 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,500 | $321,250 | |
| 7 | PFE |
Pfizer Inc
|
11,650 | $280,532 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,134,549 | 40,274 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $9,716,148 | 44,674 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $10,321,807 | 45,174 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $10,459,587 | 45,174 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $8,424,920 | 45,388 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $9,509,693 | 45,388 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $8,065,447 | 45,388 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,963,222 | 45,388 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,784,949 | 45,388 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $8,265,154 | 45,388 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $7,033,778 | 45,388 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $6,765,535 | 45,388 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $6,115,125 | 45,388 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $7,237,629 | 45,414 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $7,339,356 | 45,414 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $6,095,012 | 45,414 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $6,951,626 | 45,388 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $7,735,564 | 47,718 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $6,461,017 | 47,718 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $5,179,701 | 48,018 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,493,227 | 48,768 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $5,277,672 | 48,768 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $5,225,491 | 48,768 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $4,420,492 | 50,468 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $4,954,948 | 50,468 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $3,481,883 | 45,700 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||